This information is provided by and with permission from PhRMA (Pharmaceutical Research and Manufacturers of America®). This Medicine Assistance Tool (MAT) is a free-to-use search engine that focuses its searches on patient assistance resources available to eligible patients.
PhRMA’s member companies are committed to helping patients make more informed health care decisions by providing more transparency about medicine costs.
PhRMA and MAT have not independently verified, approved or otherwise reviewed this information. The information provided here is subject to change without notice. Please contact the individual companies with questions about the information provided on their websites.
If you don’t see an arrow by each company’s name, click on the name to show the medications with provided information. All links will open in new windows or tabs.
HUMIRA® (adalimumab)
MAVYRET™ (glecaprevir/pibrentasvir)
ORILISSA® (elagolix tablets)
SKYRIZI™ (risankizumab-rzaa)
BOTOX® (onabotulinumtoxinA) Please see full product information including boxed warning and medication guide: https://www.allergan.com/assets/pdf/botox_pi.pdf
LINZESS® (linaclotide)
LO LOESTRIN® FE (norethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate)
VRAYLAR® (cariprazine)
Myrbetriq® (Mirabegron)
BRILINTA® (ticagrelor)
FARXIGA® (dapagliflozin)
FASENRA™ (benralizumab)
SYMBICORT® (budesonide/formoterol fumarate dihydrate)
JARDIANCE® (empagliflozin)
ELIQUIS® (apixaban)
Otezla® (apremilast)
Basaglar® (insulin glargine injection)
Emgality® (galcanezumab-gnlm)
Humalog® (insulin lispro injection)
OLUMIANT® (baricitinib)
Taltz® (Ixekizumab)
Trulicity® (dulaglutide)
Verzenio™ (abemaciclib)
BIKTARVY® (bictegravir/emtricitabine/tenofovir alafenamide)
EPCLUSA® (sofosbuvir/velpatasvir)
TRUVADA (emtricitabine/tenofovir disoproxil fumarate) for PrEP®
ANORO (umeclidinium/vilanterol inhalation powder)
TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol inhalation powder)
COSENTYX® (secukinumab)
ENTRESTO® (sacubitril/valsartan)
Ozempic® (semaglutide)
REXULTI® (brexpiprazole)
Toujeo® (insulin glargine injection)
Latuda® (lurasidone HCl)
ENTYVIO® (vedolizumab)
TRINTELLIX (vortioxetine)
Briviact® (brivaracetam)
Cimzia® (certolizumab pegol)
Neupro® (rotigotine transdermal system)
Vimpat® (lacosamide)
PET studies reveal that adults with ADHD exhibit lower glucose metabolism in 30 out of…
Summer break can be especially challenging when you're parenting a child with ADHD. Disrupted routines,…
Harold Robert Meyer | The ADD Resource Center 07/03/2025 Executive Summary Couples where one or…
July 01, 2025 by addrcHarold Robert Meyer and The ADD Resource Center Why are people…
Why is it that even after we’ve made peace with someone’s actions, the memory lingers?…
Knowing that ADHD is manageable flips the script from despair to possibility. It’s not just…